C-Suite

U.S. prescription drug spending is projected to nearly double, reaching more than $1 trillion by 2030. In response, many employers are turning to independent, next-generation PBMs.

HHS, NIH among entities likely facing major impacts from Supreme Court's layoffs decision.

The Department of Education has announced that 0% loans will start accruing interest on August 1 for student loan borrowers in the legally-challenged Saving on a Valuable Education plan, while wage garnishment will begin later this summer.

A Texas federal judge ruled partially in favor of a group of financial advisors challenging the DOL's interpretation of fiduciary standards under ERISA, when it pertains to advisors offering recommendations for rollover transactions. 

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus

In this episode, we sit down with Tracy Watts, senior partner, national leader for U.S. Health Care Policy at Mercer. The wide-ranging discussion includes her thoughts on all the noise coming out of Washington D.C. right now to a few of the innovative benefits design strategies and ideas she's watching most closely right now.